Mirxes Holding Company Limited (stock code: 02629, abbreviated as “MIRXES-B”) announced that its board of directors will convene on Tuesday, 31 March 2026.
Key agenda items include: 1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY2025 results. 3. Considering a recommendation for a final dividend, if any. 4. Addressing other routine business matters.
Board composition as of the announcement date (19 March 2026) comprises: • Executive Directors: Dr. ZHOU Lihan (also Chief Executive Officer) and Dr. ZOU Ruiyang. • Non-executive Directors: Dr. TOO Heng Phon, Dr. LE Beilin and Mr. LIU Da. • Independent Non-executive Directors: Dr. LAM Sin Lai Judy, Mr. FANG Xiao and Ms. MA Andrea Lo Ling.
The meeting outcome will shape MIRXES-B’s disclosure schedule for its FY2025 performance and signal potential shareholder returns via a final dividend proposal.
Comments